Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.

ABSTRACT:

Background

Accumulating data suggest antiviral effects of povidone-iodine against the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. This narrative review aims to examine the antiviral mechanisms of povidone-iodine, efficacy of povidone-iodine against the SARS-CoV-2 virus, and safety of povidone-iodine to human epithelial cells and thyroid function.

Methods

We searched the electronic databases PubMed, Embase, Cochrane Library, ClinicalTrials.gov and World Health Organization's International Clinical Trials Registry Platform for articles containing the keywords "povidone-iodine", "SARS-CoV-2" and "COVID-19" from database inception till 3 June 2021.

Results

Despite in vitro data supporting the anti-SARS-CoV-2 effects of povidone-iodine, findi

SUBMITTER: Lim NA 

PROVIDER: S-EPMC9132411 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature